Literature DB >> 32335146

AGA Clinical Practice Update on Colorectal and Pancreatic Cancer Risk and Screening in BRCA1 and BRCA2 Carriers: Commentary.

Sonia S Kupfer1, Samir Gupta2, Jeffrey N Weitzel3, Jewel Samadder4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32335146      PMCID： PMC7483595          DOI： 10.1053/j.gastro.2020.03.086

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  32 in total

1.  Colorectal cancer in hereditary breast cancer kindreds.

Authors:  K M Lin; C A Ternent; D R Adams; A G Thorson; G J Blatchford; M A Christensen; P Watson; H T Lynch
Journal:  Dis Colon Rectum       Date:  1999-08       Impact factor: 4.585

2.  Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.

Authors:  Haley Streff; Jessica Profato; Yuanqing Ye; Denise Nebgen; Susan K Peterson; Claire Singletary; Banu K Arun; Jennifer K Litton
Journal:  Oncologist       Date:  2016-06-15

3.  Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.

Authors:  Matthew B Yurgelun; Matthew H Kulke; Charles S Fuchs; Brian A Allen; Hajime Uno; Jason L Hornick; Chinedu I Ukaegbu; Lauren K Brais; Philip G McNamara; Robert J Mayer; Deborah Schrag; Jeffrey A Meyerhardt; Kimmie Ng; John Kidd; Nanda Singh; Anne-Renee Hartman; Richard J Wenstrup; Sapna Syngal
Journal:  J Clin Oncol       Date:  2017-01-30       Impact factor: 44.544

4.  Cancer risks in BRCA2 mutation carriers.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1999-08-04       Impact factor: 13.506

5.  Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations.

Authors:  Luna Kadouri; Ayala Hubert; Yakir Rotenberg; Tamar Hamburger; Michal Sagi; Chovav Nechushtan; Dvorah Abeliovich; Tamar Peretz
Journal:  J Med Genet       Date:  2007-02-16       Impact factor: 6.318

6.  Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

Authors:  Marcia S Brose; Timothy R Rebbeck; Kathleen A Calzone; Jill E Stopfer; Katherine L Nathanson; Barbara L Weber
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

7.  Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.

Authors:  A Moran; C O'Hara; S Khan; L Shack; E Woodward; E R Maher; F Lalloo; D G R Evans
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

8.  The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients.

Authors:  R Chen-Shtoyerman; A Figer; H H Fidder; P Rath; L Yeremin; S Bar Meir; E Friedman; L Theodor
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

9.  The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  J Iqbal; A Ragone; J Lubinski; H T Lynch; P Moller; P Ghadirian; W D Foulkes; S Armel; A Eisen; S L Neuhausen; L Senter; C F Singer; P Ainsworth; C Kim-Sing; N Tung; E Friedman; M Llacuachaqui; S Ping; S A Narod
Journal:  Br J Cancer       Date:  2012-10-25       Impact factor: 7.640

10.  Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study.

Authors:  C M Phelan; J Iqbal; H T Lynch; J Lubinski; J Gronwald; P Moller; P Ghadirian; W D Foulkes; S Armel; A Eisen; S L Neuhausen; L Senter; C F Singer; P Ainsworth; C Kim-Sing; N Tung; M Llacuachaqui; G Chornokur; S Ping; S A Narod
Journal:  Br J Cancer       Date:  2013-11-28       Impact factor: 7.640
View more
  2 in total

1.  PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells.

Authors:  Changjiang Qin; Zhiyu Ji; Ertao Zhai; Kaiwu Xu; Yijie Zhang; Quanying Li; Hong Jing; Xiaoliang Wang; Xinming Song
Journal:  Cell Death Dis       Date:  2022-05-28       Impact factor: 9.685

2.  Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations.

Authors:  Louise Wang; Susan M Domchek; Michael L Kochman; Bryson W Katona
Journal:  Genes Cancer       Date:  2022-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.